These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Hepatic disposal of biosynthetic human insulin and porcine C-peptide in humans. Bratusch-Marrain PR; Waldhäusl WK; Gasić S; Hofer A Metabolism; 1984 Feb; 33(2):151-7. PubMed ID: 6141519 [TBL] [Abstract][Full Text] [Related]
7. Compared to glibenclamide, repaglinide treatment results in a more rapid fall in glucose level and beta-cell secretion after glucose stimulation. Abbink EJ; van der Wal PS; Sweep CG; Smits P; Tack CJ Diabetes Metab Res Rev; 2004; 20(6):466-71. PubMed ID: 15386823 [TBL] [Abstract][Full Text] [Related]
8. Selective suppression of hepatic glucose output by human proinsulin in the dog. Lavelle-Jones M; Scott MH; Kolterman O; Rubenstein AH; Olefsky JM; Moossa AR Am J Physiol; 1987 Feb; 252(2 Pt 1):E230-6. PubMed ID: 2881485 [TBL] [Abstract][Full Text] [Related]
9. Lack of effect of high-dose biosynthetic human C-peptide on pancreatic hormone release in normal subjects. Wojcikowski C; Blackman J; Ostrega D; Lewis G; Galloway J; Rubenstein AH; Polonsky KS Metabolism; 1990 Aug; 39(8):827-32. PubMed ID: 2198434 [TBL] [Abstract][Full Text] [Related]
10. Effect of stress hormones on splanchnic substrate and insulin disposal after glucose ingestion in healthy humans. Waldhäusl WK; Gasic S; Bratusch-Marrain P; Komjati M; Korn A Diabetes; 1987 Feb; 36(2):127-35. PubMed ID: 3542641 [TBL] [Abstract][Full Text] [Related]
11. Both relative insulin resistance and defective islet beta-cell processing of proinsulin are responsible for transient hyperglycemia in extremely preterm infants. Mitanchez-Mokhtari D; Lahlou N; Kieffer F; Magny JF; Roger M; Voyer M Pediatrics; 2004 Mar; 113(3 Pt 1):537-41. PubMed ID: 14993546 [TBL] [Abstract][Full Text] [Related]
12. Evidence against a rate-limiting role of proinsulin processing for maximal insulin secretion in subjects with impaired glucose tolerance and beta-cell dysfunction. Stumvoll M; Fritsche A; Stefan N; Hardt E; Häring H J Clin Endocrinol Metab; 2001 Mar; 86(3):1235-9. PubMed ID: 11238514 [TBL] [Abstract][Full Text] [Related]
13. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus. Shapiro ET; Van Cauter E; Tillil H; Given BD; Hirsch L; Beebe C; Rubenstein AH; Polonsky KS J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533 [TBL] [Abstract][Full Text] [Related]
14. Prolonged maximal stimulation of insulin secretion in healthy subjects does not provoke preferential release of proinsulin. Nauck MA; Siegel EG; Creutzfeldt W Pancreas; 1991 Nov; 6(6):645-52. PubMed ID: 1780324 [TBL] [Abstract][Full Text] [Related]
15. Effect of verapamil on basal and glucagon-dependent splanchnic glucose metabolism and insulin secretion in man. Gasić S; Bratusch-Marrain P; Waldhäusl W; Korn A Int J Clin Pharmacol Ther Toxicol; 1988 Jan; 26(1):36-40. PubMed ID: 3042640 [TBL] [Abstract][Full Text] [Related]
16. C-peptide and insulin secretion. Relationship between peripheral concentrations of C-peptide and insulin and their secretion rates in the dog. Polonsky KS; Pugh W; Jaspan JB; Cohen DM; Karrison T; Tager HS; Rubenstein AH J Clin Invest; 1984 Nov; 74(5):1821-9. PubMed ID: 6389599 [TBL] [Abstract][Full Text] [Related]
17. Effects of single and combined infusions of human biosynthetic proinsulin and insulin on glucose metabolism and on plasma hormone concentrations in euglycaemic clamp experiments. Nauck MA; Stöckmann F; Thiery J; Ebert R; Creutzfeldt W Horm Metab Res Suppl; 1988; 18():60-7. PubMed ID: 3056814 [TBL] [Abstract][Full Text] [Related]
18. Sustained pulsatile insulin secretion from adenomatous human beta-cells. Synchronous cycling of insulin, C-peptide, and proinsulin. Chou HF; Ipp E; Bowsher RR; Berman N; Ezrin C; Griffiths S Diabetes; 1991 Nov; 40(11):1453-8. PubMed ID: 1936605 [TBL] [Abstract][Full Text] [Related]
19. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients. van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393 [TBL] [Abstract][Full Text] [Related]